CMSC INforMS: A Letter from Lemtrada Regarding its Home Phlebotomy Partner, EMSI
Saturday, July 11, 2020
Posted by: Rachelle Ramirez
Good Day Lemtrada Patient –
On July 3, 2020 Sanofi Genzyme was notified that our Lemtrada Home Phlebotomy Partner, Examination Management Services Inc., (EMSI) has gone out of business. Because of this, unfortunately, all future Lemtrada Home Phlebotomy (lab draw) visits from EMSI have been cancelled.
Patient safety is Sanofi Genzyme’s #1 priority and we are working to provide an alternative phlebotomy solution as well as coordinate alternative testing options for your next monthly lab tests. We will be sure to communicate these alternatives to you as soon as possible. Please be on the lookout for future communication from Sanofi Genzyme on this topic.
If you have any questions related to this announcement, please:
• Contact your healthcare provider
• Contact your One to One Nurse at 1-855-557-2483
We are very sorry for this disruption.
Please see full Prescribing Information/Medication Guide, including serious side effects.
The industry news information and articles are for informational purposes only, and are not intended to represent any trends, partnerships, commitments, or research of the Consortium of MS Centers or any of it's members in any way whatsoever, nor should any party be libel in any way to the reader or to any other person, firm or corporation reading this industry news section. Although the CMSC site includes links providing direct access to other Internet sites, CMSC takes no responsibility for the content or information contained on those other sites, and does not exert any editorial or other control over those other sites. CMSC is providing information and services on the Internet as a benefit and service in furtherance of CMSC's nonprofit and tax-exempt status. CMSC makes no representations about the suitability of this information and these services for any purpose.